To elucidate biological and transcriptional processes in human tumor-associated TRM cells upon re-activation, we analyzed CD39+CD103+ TRM cells and heterogeneous CD8+ TIL treated with PMA/ionomycin. This evidence concerns the gene CD8A and neoplasm.